Exact Mass: 361.2001462

Exact Mass Matches: 361.2001462

Found 467 metabolites which its exact mass value is equals to given mass value 361.2001462, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

3-Acetylnerbowdine

Nerbowdin, 3-acetyl

C19H23NO6 (361.1525298)


   
   

1-Epideacetylbowdensine

1-Epideacetylbowdensine

C19H23NO6 (361.1525298)


   

Methyloctatropine bromide

Anisotropine methylbromide

C17H32BrNO2 (361.1616272)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists

   

Ethacridine lactate Monohydrate

Ethacridine lactate Monohydrate

C18H23N3O5 (361.16376280000003)


D000890 - Anti-Infective Agents

   

PHA-793887

N-(6,6-dimethyl-5-(1-methylpiperidine-4-carbonyl)-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl)-3-methylbutanamide

C19H31N5O2 (361.2477626)


   

4-Hydroxydecanedioylcarnitine

3-[(9-carboxy-4-hydroxynonanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H31NO7 (361.21004159999995)


4-Hydroxydecanedioylcarnitine is an acylcarnitine. More specifically, it is an 4-hydroxydecanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Hydroxydecanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 4-Hydroxydecanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Hydroxydecanedioylcarnitine

3-[(9-carboxy-3-hydroxynonanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H31NO7 (361.21004159999995)


3-Hydroxydecanedioylcarnitine is an acylcarnitine. More specifically, it is an 3-hydroxydecanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Hydroxydecanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-Hydroxydecanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Hydroxydecanedioylcarnitine

3-[(9-carboxy-5-hydroxynonanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H31NO7 (361.21004159999995)


5-Hydroxydecanedioylcarnitine is an acylcarnitine. More specifically, it is an 5-hydroxydecanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-Hydroxydecanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-Hydroxydecanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(+)-Butaclamol

3-Tert-butyl-2,3,4,4a,8,9,13b,14-octahydro-1h-benzo[6,7]cyclohepta[1,2,3-de]pyrido[2,1-a]isoquinolin-3-ol

C25H31NO (361.2405516)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants

   

Carbocromen

Ethyl 2-({3-[2-(diethylamino)ethyl]-4-methyl-2-oxo-2H-chromen-7-yl}oxy)acetic acid

C20H27NO5 (361.18891320000006)


C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

Octocrylene

2-Ethylhexyl 2-cyano-3,3-diphenylprop-2-enoic acid

C24H27NO2 (361.2041682)


C1892 - Chemopreventive Agent > C851 - Sunscreen

   

rac S 33138

N-[4-(2-{12-cyano-8-oxa-4-azatricyclo[7.4.0.0^{2,6}]trideca-1(9),10,12-trien-4-yl}ethyl)phenyl]acetamide

C22H23N3O2 (361.1790178)


   

Semagacestat

2-Hydroxy-3-methyl-N-{1-[(3-methyl-2-oxo-2,3,4,5-tetrahydro-1H-3-benzazepin-1-yl)-C-hydroxycarbonimidoyl]ethyl}butanimidate

C19H27N3O4 (361.2001462)


   

N-(4-(4-Amino-2-ethyl-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide

N-(4-(4-amino-2-Ethyl-1H-imidazo(4,5-c)quinolin-1-yl)butyl)methanesulfonamide

C17H23N5O2S (361.1572378)


C308 - Immunotherapeutic Agent > C2139 - Immunostimulant > C177174 - Toll-like Receptor Agonist

   

Leucylnegamycin

(S)-L-threo-Hexonic acid

C15H31N5O5 (361.2325076)


   
   
   
   
   
   
   
   
   
   
   
   

Methylnkolbisine

(-)-Methylnkolbisine

C19H23NO6 (361.1525298)


   
   
   

Methylevoxine

Methylevoxine

C19H23NO6 (361.1525298)


Origin: Plant; SubCategory_DNP: Alkaloids derived from anthranilic acid, Quinoline alkaloids

   

Octocrylene

Octocrylene

C24H27NO2 (361.2041682)


C1892 - Chemopreventive Agent > C851 - Sunscreen CONFIDENCE standard compound; INTERNAL_ID 2501 CONFIDENCE standard compound; INTERNAL_ID 8141 CONFIDENCE standard compound; EAWAG_UCHEM_ID 229

   
   

N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentan-1-yl)-1H-indole-3-carboxamide

N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentan-1-yl)-1H-indole-3-carboxamide

C20H28FN3O2 (361.216544)


   
   

beta-Methoxy-Mahanimbicine|Murrayamine-C

beta-Methoxy-Mahanimbicine|Murrayamine-C

C24H27NO2 (361.2041682)


   
   
   
   
   
   

20-ethyl-1alpha,8-dihydroxy-4-methyl-heteratisan-14-one|Hetereophyllin|heterophylline|heterophylline (Aconitum)

20-ethyl-1alpha,8-dihydroxy-4-methyl-heteratisan-14-one|Hetereophyllin|heterophylline|heterophylline (Aconitum)

C21H31NO4 (361.22529660000004)


   

1alphaH,5alphaH,6betaH,7alphaH,11betaH-3beta-hydroxy-11alpha-[(tetrahydro-5-oxo-furan-2-yl)methylamino]methylguaia-4(15),10(14)-dien-12,6-olide|scorzoaustriacin

1alphaH,5alphaH,6betaH,7alphaH,11betaH-3beta-hydroxy-11alpha-[(tetrahydro-5-oxo-furan-2-yl)methylamino]methylguaia-4(15),10(14)-dien-12,6-olide|scorzoaustriacin

C20H27NO5 (361.18891320000006)


   
   

methyl (2R,5S,8S,15R)-5-ethyl-6-hydroxy-2-hydroxymethyl-6-azapentacyclo[9.5.1.01,5.02,8.014,17]heptadec-11(17)-ene-15-carboxylate|N-hydroxypaxdaphnine B

methyl (2R,5S,8S,15R)-5-ethyl-6-hydroxy-2-hydroxymethyl-6-azapentacyclo[9.5.1.01,5.02,8.014,17]heptadec-11(17)-ene-15-carboxylate|N-hydroxypaxdaphnine B

C21H31NO4 (361.22529660000004)


   

1-O-acetylbulbisine

1-O-acetylbulbisine

C19H23NO6 (361.1525298)


   
   

2alpha-methoxy-6-O-methyllycorenine

2alpha-methoxy-6-O-methyllycorenine

C20H27NO5 (361.18891320000006)


   
   
   

3-[bis(1H-indol-3-yl)methyl]-1H-indole

3-[bis(1H-indol-3-yl)methyl]-1H-indole

C25H19N3 (361.15788940000004)


   

Liconosine A|N-deethyl-N,19-didehydrosachaconitine|N-deethyl-N-19-didehydrosachaconitine

Liconosine A|N-deethyl-N,19-didehydrosachaconitine|N-deethyl-N-19-didehydrosachaconitine

C21H31NO4 (361.22529660000004)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

glutaminylseryllysine

glutaminylseryllysine

C14H27N5O6 (361.1961242)


   
   
   
   
   

asparagylthreonyllysine

asparagylthreonyllysine

C14H27N5O6 (361.1961242)


   
   
   
   
   
   
   
   
   
   
   

threonylasparagyllysine

threonylasparagyllysine

C14H27N5O6 (361.1961242)


   
   
   
   
   
   
   
   

MLS001146935-01!ANISOTROPINE METHYLBROMIDE

MLS001146935-01!ANISOTROPINE METHYLBROMIDE

C17H32BrNO2 (361.1616272)


   

Ala Ala Asn Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C13H23N5O7 (361.1597408)


   

Ala Ala Ser Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C13H23N5O7 (361.1597408)


   

Ala Gly Lys Ser

(2S)-2-[(2S)-6-amino-2-{2-[(2S)-2-aminopropanamido]acetamido}hexanamido]-3-hydroxypropanoic acid

C14H27N5O6 (361.1961242)


   

Ala Gly Asn Thr

(2S,3R)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-carbamoylpropanamido]-3-hydroxybutanoic acid

C13H23N5O7 (361.1597408)


   

Ala Gly Gln Ser

(2S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-4-carbamoylbutanamido]-3-hydroxypropanoic acid

C13H23N5O7 (361.1597408)


   

Ala Gly Ser Lys

(2S)-6-amino-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-hydroxypropanamido]hexanoic acid

C14H27N5O6 (361.1961242)


   

Ala Gly Ser Gln

(2S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-hydroxypropanamido]-4-carbamoylbutanoic acid

C13H23N5O7 (361.1597408)


   

Ala Gly Thr Asn

(2S)-2-[(2S,3R)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-hydroxybutanamido]-3-carbamoylpropanoic acid

C13H23N5O7 (361.1597408)


   

Ala Lys Gly Ser

(2S)-2-{2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]acetamido}-3-hydroxypropanoic acid

C14H27N5O6 (361.1961242)


   

Ala Lys Ser Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-hydroxypropanamido]acetic acid

C14H27N5O6 (361.1961242)


   

Ala Asn Ala Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]propanamido]-3-hydroxypropanoic acid

C13H23N5O7 (361.1597408)


   

Ala Asn Gly Thr

(2S,3R)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]acetamido}-3-hydroxybutanoic acid

C13H23N5O7 (361.1597408)


   

Ala Asn Ser Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]propanoic acid

C13H23N5O7 (361.1597408)


   

Ala Asn Thr Gly

2-[(2S,3R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]-3-hydroxybutanamido]acetic acid

C13H23N5O7 (361.1597408)


   

Ala Gln Gly Ser

(2S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]acetamido}-3-hydroxypropanoic acid

C13H23N5O7 (361.1597408)


   

Ala Gln Ser Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-3-hydroxypropanamido]acetic acid

C13H23N5O7 (361.1597408)


   

Ala Ser Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]propanamido]-3-carbamoylpropanoic acid

C13H23N5O7 (361.1597408)


   

Ala Ser Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]acetamido}hexanoic acid

C14H27N5O6 (361.1961242)


   

Ala Ser Gly Gln

(2S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]acetamido}-4-carbamoylbutanoic acid

C13H23N5O7 (361.1597408)


   

Ala Ser Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]hexanamido]acetic acid

C14H27N5O6 (361.1961242)


   

Ala Ser Asn Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]propanoic acid

C13H23N5O7 (361.1597408)


   

Ala Ser Gln Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-hydroxypropanamido]-4-carbamoylbutanamido]acetic acid

C13H23N5O7 (361.1597408)


   

Ala Thr Gly Asn

(2S)-2-{2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]acetamido}-3-carbamoylpropanoic acid

C13H23N5O7 (361.1597408)


   

Ala Thr Asn Gly

2-[(2S)-2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]-3-carbamoylpropanamido]acetic acid

C13H23N5O7 (361.1597408)


   

Gly Ala Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)propanamido]hexanamido]-3-hydroxypropanoic acid

C14H27N5O6 (361.1961242)


   

Gly Ala Asn Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-carbamoylpropanamido]-3-hydroxybutanoic acid

C13H23N5O7 (361.1597408)


   

Gly Ala Gln Ser

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-4-carbamoylbutanamido]-3-hydroxypropanoic acid

C13H23N5O7 (361.1597408)


   

Gly Ala Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-hydroxypropanamido]hexanoic acid

C14H27N5O6 (361.1961242)


   

Gly Ala Ser Gln

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-hydroxypropanamido]-4-carbamoylbutanoic acid

C13H23N5O7 (361.1597408)


   

Gly Ala Thr Asn

(2S)-2-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-hydroxybutanamido]-3-carbamoylpropanoic acid

C13H23N5O7 (361.1597408)


   

Gly Gly Lys Thr

(2S,3R)-2-[(2S)-6-amino-2-[2-(2-aminoacetamido)acetamido]hexanamido]-3-hydroxybutanoic acid

C14H27N5O6 (361.1961242)


   

Gly Gly Gln Thr

(2S,3R)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-4-carbamoylbutanamido]-3-hydroxybutanoic acid

C13H23N5O7 (361.1597408)


   

Gly Gly Thr Lys

(2S)-6-amino-2-[(2S,3R)-2-[2-(2-aminoacetamido)acetamido]-3-hydroxybutanamido]hexanoic acid

C14H27N5O6 (361.1961242)


   

Gly Gly Thr Gln

(2S)-2-[(2S,3R)-2-[2-(2-aminoacetamido)acetamido]-3-hydroxybutanamido]-4-carbamoylbutanoic acid

C13H23N5O7 (361.1597408)


   

Gly Lys Ala Ser

(2S)-2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]propanamido]-3-hydroxypropanoic acid

C14H27N5O6 (361.1961242)


   

Gly Lys Gly Thr

(2S,3R)-2-{2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]acetamido}-3-hydroxybutanoic acid

C14H27N5O6 (361.1961242)


   

Gly Lys Ser Ala

(2S)-2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-hydroxypropanamido]propanoic acid

C14H27N5O6 (361.1961242)


   

Gly Lys Thr Gly

2-[(2S,3R)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-hydroxybutanamido]acetic acid

C14H27N5O6 (361.1961242)


   

Gly Asn Ala Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]propanamido]-3-hydroxybutanoic acid

C13H23N5O7 (361.1597408)


   

Gly Asn Thr Ala

(2S)-2-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-hydroxybutanamido]propanoic acid

C13H23N5O7 (361.1597408)


   

Gly Gln Ala Ser

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]propanamido]-3-hydroxypropanoic acid

C13H23N5O7 (361.1597408)


   

Gly Gln Gly Thr

(2S,3R)-2-{2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]acetamido}-3-hydroxybutanoic acid

C13H23N5O7 (361.1597408)


   

Gly Gln Ser Ala

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-hydroxypropanamido]propanoic acid

C13H23N5O7 (361.1597408)


   

Gly Gln Thr Gly

2-[(2S,3R)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]-3-hydroxybutanamido]acetic acid

C13H23N5O7 (361.1597408)


   

Gly Ser Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]propanamido]hexanoic acid

C14H27N5O6 (361.1961242)


   

Gly Ser Ala Gln

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]propanamido]-4-carbamoylbutanoic acid

C13H23N5O7 (361.1597408)


   

Gly Ser Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]hexanamido]propanoic acid

C14H27N5O6 (361.1961242)


   

Gly Ser Gln Ala

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-4-carbamoylbutanamido]propanoic acid

C13H23N5O7 (361.1597408)


   

Gly Thr Ala Asn

(2S)-2-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]propanamido]-3-carbamoylpropanoic acid

C13H23N5O7 (361.1597408)


   

Gly Thr Gly Lys

(2S)-6-amino-2-{2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]acetamido}hexanoic acid

C14H27N5O6 (361.1961242)


   

Gly Thr Gly Gln

(2S)-2-{2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]acetamido}-4-carbamoylbutanoic acid

C13H23N5O7 (361.1597408)


   

Gly Thr Lys Gly

2-[(2S)-6-amino-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]hexanamido]acetic acid

C14H27N5O6 (361.1961242)


   

Gly Thr Asn Ala

(2S)-2-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-3-carbamoylpropanamido]propanoic acid

C13H23N5O7 (361.1597408)


   

Gly Thr Gln Gly

2-[(2S)-2-[(2S,3R)-2-(2-aminoacetamido)-3-hydroxybutanamido]-4-carbamoylbutanamido]acetic acid

C13H23N5O7 (361.1597408)


   
   
   

Lys Ala Gly Ser

(2S)-2-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]acetamido}-3-hydroxypropanoic acid

C14H27N5O6 (361.1961242)


   

Lys Ala Ser Gly

2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-hydroxypropanamido]acetic acid

C14H27N5O6 (361.1961242)


   

Lys Gly Ala Ser

(2S)-2-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}propanamido]-3-hydroxypropanoic acid

C14H27N5O6 (361.1961242)


   

Lys Gly Gly Thr

(2S,3R)-2-(2-{2-[(2S)-2,6-diaminohexanamido]acetamido}acetamido)-3-hydroxybutanoic acid

C14H27N5O6 (361.1961242)


   

Lys Gly Ser Ala

(2S)-2-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-hydroxypropanamido]propanoic acid

C14H27N5O6 (361.1961242)


   

Lys Gly Thr Gly

2-[(2S,3R)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-hydroxybutanamido]acetic acid

C14H27N5O6 (361.1961242)


   

Lys Ser Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]propanamido]acetic acid

C14H27N5O6 (361.1961242)


   

Lys Ser Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]acetamido}propanoic acid

C14H27N5O6 (361.1961242)


   

Lys Thr Gly Gly

2-{2-[(2S,3R)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxybutanamido]acetamido}acetic acid

C14H27N5O6 (361.1961242)


   
   
   
   
   

Asn Ala Ala Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]propanamido]-3-hydroxypropanoic acid

C13H23N5O7 (361.1597408)


   

Asn Ala Gly Thr

(2S,3R)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]acetamido}-3-hydroxybutanoic acid

C13H23N5O7 (361.1597408)


   

Asn Ala Ser Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-3-hydroxypropanamido]propanoic acid

C13H23N5O7 (361.1597408)


   

Asn Ala Thr Gly

2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]-3-hydroxybutanamido]acetic acid

C13H23N5O7 (361.1597408)


   

Asn Gly Ala Thr

(2S,3R)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}propanamido]-3-hydroxybutanoic acid

C13H23N5O7 (361.1597408)


   

Asn Gly Thr Ala

(2S)-2-[(2S,3R)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-hydroxybutanamido]propanoic acid

C13H23N5O7 (361.1597408)


   
   
   
   

Asn Ser Ala Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]propanamido]propanoic acid

C13H23N5O7 (361.1597408)


   
   

Asn Thr Ala Gly

2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]propanamido]acetic acid

C13H23N5O7 (361.1597408)


   

Asn Thr Gly Ala

(2S)-2-{2-[(2S,3R)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxybutanamido]acetamido}propanoic acid

C13H23N5O7 (361.1597408)


   
   
   
   

Gln Ala Gly Ser

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]acetamido}-3-hydroxypropanoic acid

C13H23N5O7 (361.1597408)


   

Gln Ala Ser Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]-3-hydroxypropanamido]acetic acid

C13H23N5O7 (361.1597408)


   

Gln Gly Ala Ser

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}propanamido]-3-hydroxypropanoic acid

C13H23N5O7 (361.1597408)


   

Gln Gly Gly Thr

(2S,3R)-2-(2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}acetamido)-3-hydroxybutanoic acid

C13H23N5O7 (361.1597408)


   

Gln Gly Ser Ala

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-3-hydroxypropanamido]propanoic acid

C13H23N5O7 (361.1597408)


   

Gln Gly Thr Gly

2-[(2S,3R)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-3-hydroxybutanamido]acetic acid

C13H23N5O7 (361.1597408)


   

Gln Ser Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]propanamido]acetic acid

C13H23N5O7 (361.1597408)


   

Gln Ser Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxypropanamido]acetamido}propanoic acid

C13H23N5O7 (361.1597408)


   

Gln Thr Gly Gly

2-{2-[(2S,3R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxybutanamido]acetamido}acetic acid

C13H23N5O7 (361.1597408)


   
   
   
   
   

Ser Ala Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]propanamido]-3-carbamoylpropanoic acid

C13H23N5O7 (361.1597408)


   

Ser Ala Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]acetamido}hexanoic acid

C14H27N5O6 (361.1961242)


   

Ser Ala Gly Gln

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]acetamido}-4-carbamoylbutanoic acid

C13H23N5O7 (361.1597408)


   

Ser Ala Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]hexanamido]acetic acid

C14H27N5O6 (361.1961242)


   

Ser Ala Asn Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-3-carbamoylpropanamido]propanoic acid

C13H23N5O7 (361.1597408)


   

Ser Ala Gln Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]propanamido]-4-carbamoylbutanamido]acetic acid

C13H23N5O7 (361.1597408)


   

Ser Gly Ala Lys

(2S)-6-amino-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}propanamido]hexanoic acid

C14H27N5O6 (361.1961242)


   

Ser Gly Ala Gln

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}propanamido]-4-carbamoylbutanoic acid

C13H23N5O7 (361.1597408)


   

Ser Gly Lys Ala

(2S)-2-[(2S)-6-amino-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}hexanamido]propanoic acid

C14H27N5O6 (361.1961242)


   

Ser Gly Gln Ala

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-4-carbamoylbutanamido]propanoic acid

C13H23N5O7 (361.1597408)


   
   

Ser Lys Ala Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]propanamido]acetic acid

C14H27N5O6 (361.1961242)


   

Ser Lys Gly Ala

(2S)-2-{2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]acetamido}propanoic acid

C14H27N5O6 (361.1961242)


   

Ser Asn Ala Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]propanamido]propanoic acid

C13H23N5O7 (361.1597408)


   
   

Ser Gln Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]propanamido]acetic acid

C13H23N5O7 (361.1597408)


   

Ser Gln Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carbamoylbutanamido]acetamido}propanoic acid

C13H23N5O7 (361.1597408)


   
   

Thr Ala Gly Asn

(2S)-2-{2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanamido]acetamido}-3-carbamoylpropanoic acid

C13H23N5O7 (361.1597408)


   

Thr Ala Asn Gly

2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanamido]-3-carbamoylpropanamido]acetic acid

C13H23N5O7 (361.1597408)


   

Thr Gly Ala Asn

(2S)-2-[(2S)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}propanamido]-3-carbamoylpropanoic acid

C13H23N5O7 (361.1597408)


   

Thr Gly Gly Lys

(2S)-6-amino-2-(2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}acetamido)hexanoic acid

C14H27N5O6 (361.1961242)


   

Thr Gly Gly Gln

(2S)-2-(2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}acetamido)-4-carbamoylbutanoic acid

C13H23N5O7 (361.1597408)


   

Thr Gly Lys Gly

2-[(2S)-6-amino-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}hexanamido]acetic acid

C14H27N5O6 (361.1961242)


   

Thr Gly Asn Ala

(2S)-2-[(2S)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}-3-carbamoylpropanamido]propanoic acid

C13H23N5O7 (361.1597408)


   

Thr Gly Gln Gly

2-[(2S)-2-{2-[(2S,3R)-2-amino-3-hydroxybutanamido]acetamido}-4-carbamoylbutanamido]acetic acid

C13H23N5O7 (361.1597408)


   

Thr Lys Gly Gly

2-{2-[(2S)-6-amino-2-[(2S,3R)-2-amino-3-hydroxybutanamido]hexanamido]acetamido}acetic acid

C14H27N5O6 (361.1961242)


   

Thr Asn Ala Gly

2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]propanamido]acetic acid

C13H23N5O7 (361.1597408)


   

Thr Asn Gly Ala

(2S)-2-{2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carbamoylpropanamido]acetamido}propanoic acid

C13H23N5O7 (361.1597408)


   

Thr Gln Gly Gly

2-{2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-carbamoylbutanamido]acetamido}acetic acid

C13H23N5O7 (361.1597408)


   

anti-testosterone-3-CMO

2-[(E)-[(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-ylidene]amino]oxyacetic acid

C21H31NO4 (361.22529660000004)


   
   

Cinchonan-9-amine, 10,11-dihydro-6-methoxy-, trihydrochloride , (9R)

Cinchonan-9-amine, 10,11-dihydro-6-methoxy-, trihydrochloride , (9R)

C20H28ClN3O (361.19207880000005)


   

Levophenacylmorphan

Levophenacylmorphan

C24H27NO2 (361.2041682)


   

Urea, N-[(2-chloro-6-methoxy-3-quinolinyl)methyl]-N-cyclopentyl-N,N-dimethyl- (9CI)

Urea, N-[(2-chloro-6-methoxy-3-quinolinyl)methyl]-N-cyclopentyl-N,N-dimethyl- (9CI)

C19H24ClN3O2 (361.1556954)


   

bis((r)-(-)-1-(1-naphthyl)ethyl)amine

bis((r)-(-)-1-(1-naphthyl)ethyl)amine

C24H24ClN (361.15971740000003)


   

bis((s)-(+)-1-(1-naphthyl)ethyl)amine

bis((s)-(+)-1-(1-naphthyl)ethyl)amine

C24H24ClN (361.15971740000003)


   

1-[(2-methylpropan-2-yl)oxycarbonyl]-4-oxospiro[3H-chromene-2,4-piperidine]-6-carboxylic acid

1-[(2-methylpropan-2-yl)oxycarbonyl]-4-oxospiro[3H-chromene-2,4-piperidine]-6-carboxylic acid

C19H23NO6 (361.1525298)


   

Butaclamol

(+)-BUTACLAMOL

C25H31NO (361.2405516)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants

   

6-(4-(Ethoxycarbonyl)piperazin-1-yl)pyridine-3-boronic acid pinacol ester

6-(4-(Ethoxycarbonyl)piperazin-1-yl)pyridine-3-boronic acid pinacol ester

C18H28BN3O4 (361.21727580000004)


   

3-Pyridinemethanol, 4-(4-fluoro-2-hydroxyphenyl)-a-methyl-2,6-bis(1-methylethyl)-5-propyl-

3-Pyridinemethanol, 4-(4-fluoro-2-hydroxyphenyl)-a-methyl-2,6-bis(1-methylethyl)-5-propyl-

C22H32FNO2 (361.2416944)


   
   

3-Pyridinemethanol, 4-(4-fluoro-2-hydroxyphenyl)-a-methyl-2,6-bis(1-methylethyl)-5-propyl-, (aR,4R)- (9CI)

3-Pyridinemethanol, 4-(4-fluoro-2-hydroxyphenyl)-a-methyl-2,6-bis(1-methylethyl)-5-propyl-, (aR,4R)- (9CI)

C22H32FNO2 (361.2416944)


   

(+/-)-butaclamol hcl

(+/-)-butaclamol hcl

C25H31NO (361.2405516)


   

3-(3-imidazo[1,2-b]pyridazin-2-ylphenyl)-5-(piperazin-1-ylmethyl)-1,2,4-oxadiazole

3-(3-imidazo[1,2-b]pyridazin-2-ylphenyl)-5-(piperazin-1-ylmethyl)-1,2,4-oxadiazole

C19H19N7O (361.1651004)


   

methyl 5-[tert-butyl(dimethyl)silyl]oxy-4-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoate

methyl 5-[tert-butyl(dimethyl)silyl]oxy-4-[(2-methylpropan-2-yl)oxycarbonylamino]pentanoate

C17H35NO5Si (361.228438)


   

1-(Piperidin-1-yl)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propan-2-ol

1-(Piperidin-1-yl)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propan-2-ol

C20H32BNO4 (361.2424262)


   
   

4-Cyanophenyl trans-4-(4-butylcyclohexyl)benzoate

4-Cyanophenyl trans-4-(4-butylcyclohexyl)benzoate

C24H27NO2 (361.2041682)


   

3,3-diphenyl-N-(3-phenylsulfanylpropyl)propan-1-amine

3,3-diphenyl-N-(3-phenylsulfanylpropyl)propan-1-amine

C24H27NS (361.18641020000007)


   

BENZYL N-BOC-4-ISOPROPYL-4-PIPERIDINECARBOXYLATE

BENZYL N-BOC-4-ISOPROPYL-4-PIPERIDINECARBOXYLATE

C21H31NO4 (361.22529660000004)


   
   
   

N-([1,1-biphenyl]-4-yl)-9,9-dimethyl-9H-fluoren-2-amine

N-([1,1-biphenyl]-4-yl)-9,9-dimethyl-9H-fluoren-2-amine

C27H23N (361.1830398)


   

1,3-Propanediamine,N1,N1-diethyl-N3-(6-methyl-5H-pyrido[3,4:4,5]pyrrolo[2,3-g]isoquinolin-10-yl)-

1,3-Propanediamine,N1,N1-diethyl-N3-(6-methyl-5H-pyrido[3,4:4,5]pyrrolo[2,3-g]isoquinolin-10-yl)-

C22H27N5 (361.22663420000003)


   

butyl prop-2-enoate,N-(methoxymethyl)-2-methylprop-2-enamide,styrene

butyl prop-2-enoate,N-(methoxymethyl)-2-methylprop-2-enamide,styrene

C21H31NO4 (361.22529660000004)


   
   

tert-Butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-benzo[b][1,4]oxazine-4(3H)-carboxylate

tert-Butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2H-benzo[b][1,4]oxazine-4(3H)-carboxylate

C19H28BNO5 (361.20604280000003)


   

(2R)-2-[(4-tert-butylphenyl)methyl]-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid

(2R)-2-[(4-tert-butylphenyl)methyl]-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid

C21H31NO4 (361.22529660000004)


   

2-[[4-[bis(2-hydroxyethyl)amino]phenyl]amino]-5-[(2-hydroxyethyl)amino]cyclohexa-2,5-diene-1,4-dione

2-[[4-[bis(2-hydroxyethyl)amino]phenyl]amino]-5-[(2-hydroxyethyl)amino]cyclohexa-2,5-diene-1,4-dione

C18H23N3O5 (361.16376280000003)


   

Semagacestat

Semagacestat(LY450139)

C19H27N3O4 (361.2001462)


D004791 - Enzyme Inhibitors > D000091062 - Gamma Secretase Inhibitors and Modulators C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

Methanone, [4-(5-chloro-2-methylphenyl)-1-piperazinyl][3-methyl-5-(1-methylethyl)-4-isoxazolyl]

Methanone, [4-(5-chloro-2-methylphenyl)-1-piperazinyl][3-methyl-5-(1-methylethyl)-4-isoxazolyl]

C19H24ClN3O2 (361.1556954)


   

1-TRIISOPROPYLSILANYL-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXYLIC ACID METHOXY-METHYL-AMIDE

1-TRIISOPROPYLSILANYL-1H-PYRROLO[2,3-B]PYRIDINE-5-CARBOXYLIC ACID METHOXY-METHYL-AMIDE

C19H31N3O2Si (361.2185426)


   

N-[1,1-Biphenyl]-4-yl-9,9-dimethyl-9H-fluoren-3-amine

N-[1,1-Biphenyl]-4-yl-9,9-dimethyl-9H-fluoren-3-amine

C27H23N (361.1830398)


   

Furethidine

ethyl 1-[2-(oxolan-2-ylmethoxy)ethyl]-4-phenylpiperidine-4-carboxylate

C21H31NO4 (361.22529660000004)


C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist

   

N-[1,1-Biphenyl]-2-yl-9,9-dimethyl-9H-fluoren-2-amine

N-[1,1-Biphenyl]-2-yl-9,9-dimethyl-9H-fluoren-2-amine

C27H23N (361.1830398)


   

Tert-Butyl(S)-1-((S)-3-methyl-2-oxo-2,3,4,5-tetrahydro-1H-benzo[d]azepin-1-ylamino)-1-oxopropan-2-ylcarbamate

Tert-Butyl(S)-1-((S)-3-methyl-2-oxo-2,3,4,5-tetrahydro-1H-benzo[d]azepin-1-ylamino)-1-oxopropan-2-ylcarbamate

C19H27N3O4 (361.2001462)


   

6-[2-(Dimethoxymethyl)-4-(6-methyl-2-pyridinyl)-1H-imidazol-5-yl] quinoxaline

6-[2-(Dimethoxymethyl)-4-(6-methyl-2-pyridinyl)-1H-imidazol-5-yl] quinoxaline

C20H19N5O2 (361.1538674)


   

2-(diethylamino)ethyl 2,2-diphenylpropanoate,hydrochloride

2-(diethylamino)ethyl 2,2-diphenylpropanoate,hydrochloride

C21H28ClNO2 (361.18084580000004)


   

4-((4-(DIETHYLAMINO)PHENYL)IMINO)-N-METHYL-1-OXO-1,4-DIHYDRONAPHTHALENE-2-CARBOXAMIDE

4-((4-(DIETHYLAMINO)PHENYL)IMINO)-N-METHYL-1-OXO-1,4-DIHYDRONAPHTHALENE-2-CARBOXAMIDE

C22H23N3O2 (361.1790178)


   

BOC-(S)-ALPHA-(4-TERT-BUTYL-BENZYL)-PROLINE

BOC-(S)-ALPHA-(4-TERT-BUTYL-BENZYL)-PROLINE

C21H31NO4 (361.22529660000004)


   

3-(2-Methoxy-5-methylphenyl)-3-phenylpropanol

3-(2-Methoxy-5-methylphenyl)-3-phenylpropanol

C22H32ClNO (361.2172292)


   

1-Butanol, 4-[(5,6-diphenyl-2-pyrazinyl)(1-methylethyl)amino]-

1-Butanol, 4-[(5,6-diphenyl-2-pyrazinyl)(1-methylethyl)amino]-

C23H27N3O (361.21540120000003)


   

N-cyclohexyl-2-(4-(4,4,5,5-tetramethyl-1,3-dioxolan-2-yl)phenoxy)acetamide

N-cyclohexyl-2-(4-(4,4,5,5-tetramethyl-1,3-dioxolan-2-yl)phenoxy)acetamide

C21H31NO4 (361.22529660000004)


   

5,7-dihydro-7,7-diMethyl-5-phenyl-indeno[2,1-b]carbazole

5,7-dihydro-7,7-diMethyl-5-phenyl-indeno[2,1-b]carbazole

C27H23N (361.1830398)


   

Dapiprazole Hydrochloride

Dapiprazole Hydrochloride

C19H28ClN5 (361.20331180000005)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants Dapiprazole hydrochloride is a potent, selective and orally active alpha-1 adrenoceptor antagonist. Dapiprazole hydrochloride suppresses the opioid withdrawal symptoms. Dapiprazole hydrochloride is also used as eye drops for reversing mydriasis[1][2][3].

   

Decyl 2-acetamido-2-deoxy-β-D-glucopyranoside

Decyl 2-acetamido-2-deoxy-β-D-glucopyranoside

C18H35NO6 (361.24642500000004)


   

2-(1-(tert-Butoxycarbonyl)spiro[chroman-2,4-piperidine]-4-yl)acetic acid

2-(1-(tert-Butoxycarbonyl)spiro[chroman-2,4-piperidine]-4-yl)acetic acid

C20H27NO5 (361.18891320000006)


   

buquinolate

buquinolate

C20H27NO5 (361.18891320000006)


C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent

   

N-(Triphenylmethyl)-DL-serine Methyl Ester

N-(Triphenylmethyl)-DL-serine Methyl Ester

C23H23NO3 (361.16778480000005)


   

Bradanicline

Bradanicline

C22H23N3O2 (361.1790178)


C78272 - Agent Affecting Nervous System Bradanicline is a highly selective α7 nicotinic acetylcholine receptor (nAChR) agonist (humanα7 nAChR: EC50=17 nM; Ki= 1.4 nM). Bradanicline is used for the research of cognitive disorders[1][2].

   

Prenoxdiazine

Prenoxdiazine

C23H27N3O (361.21540120000003)


R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent

   

1-[(2S)-2-(dimethylamino)-3-(4-hydroxyphenyl)propyl]-3-[(2S)-1-(thiophen-3-yl)propan-2-yl]urea

1-[(2S)-2-(dimethylamino)-3-(4-hydroxyphenyl)propyl]-3-[(2S)-1-(thiophen-3-yl)propan-2-yl]urea

C19H27N3O2S (361.1823882)


PZM21 is a potent and selective μ opioid receptor agonist with an EC50 of 1.8 nM[1][2][3].

   

Veliflapon

Veliflapon

C23H23NO3 (361.16778480000005)


D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D004791 - Enzyme Inhibitors > D016859 - Lipoxygenase Inhibitors D002491 - Central Nervous System Agents > D000700 - Analgesics C78274 - Agent Affecting Cardiovascular System D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

Etafenone hydrochloride

Etafenone hydrochloride

C21H28ClNO2 (361.18084580000004)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

Tributyl(2,4-dichlorobenzyl)phosphonium

Tributyl(2,4-dichlorobenzyl)phosphonium

C19H32Cl2P+ (361.1618562)


   
   

Butaclamol free base

Butaclamol free base

C25H31NO (361.2405516)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist

   

2-[(4-phenyl-1-piperazinyl)methyl]-3,6-dihydro-2H-imidazo[1,2-c]quinazolin-5-one

2-[(4-phenyl-1-piperazinyl)methyl]-3,6-dihydro-2H-imidazo[1,2-c]quinazolin-5-one

C21H23N5O (361.1902508)


   

N-(3,4-dimethoxyphenyl)-1-(3-methylphenyl)-4-pyrazolo[3,4-d]pyrimidinamine

N-(3,4-dimethoxyphenyl)-1-(3-methylphenyl)-4-pyrazolo[3,4-d]pyrimidinamine

C20H19N5O2 (361.1538674)


   

N-(1-adamantyl)-4-[oxo(2-oxolanyl)methyl]-1-piperazinecarboxamide

N-(1-adamantyl)-4-[oxo(2-oxolanyl)methyl]-1-piperazinecarboxamide

C20H31N3O3 (361.23652960000004)


   

L-Seryl-L-lysyl-L-lysine

L-Seryl-L-lysyl-L-lysine

C15H31N5O5 (361.2325076)


   

8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide

8-Methyl-3-(2-propylpentanoyloxy)tropinium bromide

C17H32BrNO2 (361.1616272)


   

N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine

N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine

C18H18F3N5 (361.1514224)


   

D-Naphthyl-1-Acetamido Boronic Acid Alanine

D-Naphthyl-1-Acetamido Boronic Acid Alanine

C17H22BN2O6- (361.15708420000004)


   

L-Naphthyl-1-Acetamido Boronic Acid Alanine

L-Naphthyl-1-Acetamido Boronic Acid Alanine

C17H22BN2O6- (361.15708420000004)


   

Pharmakon1600-01506187

Pharmakon1600-01506187

C24H27NO2 (361.2041682)


   
   

(6R)-3,5,6-trihydroxy-2-(3-methylbutanoyl)-4,6-bis(3-methylbut-2-enyl)cyclo

(6R)-3,5,6-trihydroxy-2-(3-methylbutanoyl)-4,6-bis(3-methylbut-2-enyl)cyclo

C21H29O5- (361.2014884)


   

(4R)-4,5-dihydroxy-2-(2-methylbutanoyl)-4,6-bis(3-methylbut-2-enyl)-3-oxocyclohexa-1,5-dien-1-olate

(4R)-4,5-dihydroxy-2-(2-methylbutanoyl)-4,6-bis(3-methylbut-2-enyl)-3-oxocyclohexa-1,5-dien-1-olate

C21H29O5- (361.2014884)


   
   
   
   
   

(2S)-6-amino-2-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-hydroxypropanoyl]amino]hexanoic acid

(2S)-6-amino-2-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-hydroxypropanoyl]amino]hexanoic acid

C15H31N5O5 (361.2325076)


   

2-[4-[2-[[(2R)-2-hydroxy-3-phenoxypropyl]amino]ethoxy]phenoxy]acetic acid

2-[4-[2-[[(2R)-2-hydroxy-3-phenoxypropyl]amino]ethoxy]phenoxy]acetic acid

C19H23NO6 (361.1525298)


   

11-[2-(Diethylamino)ethylamino]-7,8,9,10-tetrahydrobenzimidazolo[1,2-b]isoquinoline-6-carbonitrile

11-[2-(Diethylamino)ethylamino]-7,8,9,10-tetrahydrobenzimidazolo[1,2-b]isoquinoline-6-carbonitrile

C22H27N5 (361.22663420000003)


   

azanigerone D

azanigerone D

C19H23NO6 (361.1525298)


An azaphilone that is the ester obtained by formal condensation of the carboxy group of 2,4-dimethylhexanoic acid with the tertiary hydroxy group of 7-hydroxy-7-methyl-6,8-dioxo-2,6,7,8-tetrahydroisoquinoline-3-carboxylic acid.

   

N-[4-(dimethylamino)phenyl]-2-(1-oxo-[1,2,4]triazino[4,5-a]indol-2-yl)acetamide

N-[4-(dimethylamino)phenyl]-2-(1-oxo-[1,2,4]triazino[4,5-a]indol-2-yl)acetamide

C20H19N5O2 (361.1538674)


   

4-[4-(2,3-dimethylphenyl)piperazine-1-carbonyl]-1H-quinolin-2-one

4-[4-(2,3-dimethylphenyl)piperazine-1-carbonyl]-1H-quinolin-2-one

C22H23N3O2 (361.1790178)


   

Ethyl 4-{[1-(ethylsulfonyl)piperidin-4-yl]carbonyl}piperazine-1-carboxylate

Ethyl 4-{[1-(ethylsulfonyl)piperidin-4-yl]carbonyl}piperazine-1-carboxylate

C15H27N3O5S (361.1671332)


   

3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)propanamide

3-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)propanamide

C22H23N3O2 (361.1790178)


   

1-[4-(2,3-Dimethylphenyl)-1-piperazinyl]-2-(1-methyl-3-indolyl)ethanone

1-[4-(2,3-Dimethylphenyl)-1-piperazinyl]-2-(1-methyl-3-indolyl)ethanone

C23H27N3O (361.21540120000003)


   

1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea

1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea

C16H22F3N3O3 (361.1613178)


   

5-[[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-4-pyrazolylidene]methylamino]-1,3-dihydrobenzimidazol-2-one

5-[[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-4-pyrazolylidene]methylamino]-1,3-dihydrobenzimidazol-2-one

C20H19N5O2 (361.1538674)


   

(4Z,7Z,10Z,13Z,15E,17S)-17-hydroperoxydocosa-4,7,10,13,15-pentaenoate

(4Z,7Z,10Z,13Z,15E,17S)-17-hydroperoxydocosa-4,7,10,13,15-pentaenoate

C22H33O4- (361.23787180000005)


   

(7Z,10Z,13Z,15E,19Z)-17-hydroperoxydocosa-7,10,13,15,19-pentaenoate

(7Z,10Z,13Z,15E,19Z)-17-hydroperoxydocosa-7,10,13,15,19-pentaenoate

C22H33O4- (361.23787180000005)


   

(7Z,10Z,12E,16Z,19Z)-14-hydroperoxydocosa-7,10,12,16,19-pentaenoate

(7Z,10Z,12E,16Z,19Z)-14-hydroperoxydocosa-7,10,12,16,19-pentaenoate

C22H33O4- (361.23787180000005)


   

(4Z,7Z,10Z,12E,16Z)-14-hydroperoxydocosa-4,7,10,12,16-pentaenoate

(4Z,7Z,10Z,12E,16Z)-14-hydroperoxydocosa-4,7,10,12,16-pentaenoate

C22H33O4- (361.23787180000005)


   
   
   
   
   
   
   
   
   

(8E,10Z,14E,16Z,19Z)-7,13-dihydroxydocosa-8,10,14,16,19-pentaenoate

(8E,10Z,14E,16Z,19Z)-7,13-dihydroxydocosa-8,10,14,16,19-pentaenoate

C22H33O4- (361.23787180000005)


   

2-[2-Hex-1-ynyl-6-(methylamino)-9-purinyl]-5-(hydroxymethyl)oxolane-3,4-diol

2-[2-Hex-1-ynyl-6-(methylamino)-9-purinyl]-5-(hydroxymethyl)oxolane-3,4-diol

C17H23N5O4 (361.17499580000003)


   

2-(dimethylamino)-1-[(1S,5R)-7-[4-[(E)-2-phenylethenyl]phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]ethanone

2-(dimethylamino)-1-[(1S,5R)-7-[4-[(E)-2-phenylethenyl]phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]ethanone

C23H27N3O (361.21540120000003)


   

(2S,3S,3aR,9bR)-1-(cyclopentylcarbamoyl)-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid

(2S,3S,3aR,9bR)-1-(cyclopentylcarbamoyl)-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid

C18H23N3O5 (361.16376280000003)


   

(2R,3R,3aS,9bS)-1-(cyclopentylcarbamoyl)-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid

(2R,3R,3aS,9bS)-1-(cyclopentylcarbamoyl)-3-(hydroxymethyl)-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid

C18H23N3O5 (361.16376280000003)


   

2-[(1R,3R,4aR,9aS)-6-[(2-cyclopropyl-1-oxoethyl)amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

2-[(1R,3R,4aR,9aS)-6-[(2-cyclopropyl-1-oxoethyl)amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

C19H23NO6 (361.1525298)


   

2-[(1R,3R,4aS,9aR)-6-[(2-cyclopropyl-1-oxoethyl)amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

2-[(1R,3R,4aS,9aR)-6-[(2-cyclopropyl-1-oxoethyl)amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

C19H23NO6 (361.1525298)


   

2-[(1S,3R,4aR,9aS)-6-[(2-cyclopropyl-1-oxoethyl)amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

2-[(1S,3R,4aR,9aS)-6-[(2-cyclopropyl-1-oxoethyl)amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

C19H23NO6 (361.1525298)


   

N-[[(2R,3S,4R)-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)-N-propan-2-ylacetamide

N-[[(2R,3S,4R)-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)-N-propan-2-ylacetamide

C20H31N3O3 (361.23652960000004)


   

N-[[(2R,3S,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

N-[[(2R,3S,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

C19H27N3O4 (361.2001462)


   

N-[[(2R,3S,4R)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

N-[[(2R,3S,4R)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

C19H27N3O4 (361.2001462)


   

4-[(3aR,4S,9bS)-1-acetyl-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile

4-[(3aR,4S,9bS)-1-acetyl-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile

C22H23N3O2 (361.1790178)


   

2-[(1S,3S,4aS,9aR)-6-[(2-cyclopropyl-1-oxoethyl)amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

2-[(1S,3S,4aS,9aR)-6-[(2-cyclopropyl-1-oxoethyl)amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

C19H23NO6 (361.1525298)


   

2-[(1R,3S,4aR,9aS)-6-[(2-cyclopropyl-1-oxoethyl)amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

2-[(1R,3S,4aR,9aS)-6-[(2-cyclopropyl-1-oxoethyl)amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

C19H23NO6 (361.1525298)


   

2-[(1S,3R,4aS,9aR)-6-[(2-cyclopropyl-1-oxoethyl)amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

2-[(1S,3R,4aS,9aR)-6-[(2-cyclopropyl-1-oxoethyl)amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

C19H23NO6 (361.1525298)


   

2-[(1S,3S,4aR,9aS)-6-[(2-cyclopropyl-1-oxoethyl)amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

2-[(1S,3S,4aR,9aS)-6-[(2-cyclopropyl-1-oxoethyl)amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

C19H23NO6 (361.1525298)


   

2-[(1R,3S,4aS,9aR)-6-[(2-cyclopropyl-1-oxoethyl)amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

2-[(1R,3S,4aS,9aR)-6-[(2-cyclopropyl-1-oxoethyl)amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid

C19H23NO6 (361.1525298)


   

N-[[(2S,3R,4S)-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)-N-propan-2-ylacetamide

N-[[(2S,3R,4S)-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)-N-propan-2-ylacetamide

C20H31N3O3 (361.23652960000004)


   

[(2R,3S,4S)-1-(4-ethyl-2-thiazolyl)-4-[(2-methoxyethylamino)methyl]-3-phenyl-2-azetidinyl]methanol

[(2R,3S,4S)-1-(4-ethyl-2-thiazolyl)-4-[(2-methoxyethylamino)methyl]-3-phenyl-2-azetidinyl]methanol

C19H27N3O2S (361.1823882)


   

N-[[(2R,3R,4R)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

N-[[(2R,3R,4R)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

C19H27N3O4 (361.2001462)


   

N-[[(2S,3S,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

N-[[(2S,3S,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

C19H27N3O4 (361.2001462)


   

N-[[(2R,3R,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

N-[[(2R,3R,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

C19H27N3O4 (361.2001462)


   

N-[[(2S,3R,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

N-[[(2S,3R,4S)-1-acetyl-4-(hydroxymethyl)-3-phenyl-2-azetidinyl]methyl]-2-(4-morpholinyl)acetamide

C19H27N3O4 (361.2001462)


   

4-[(3aS,4R,9bR)-1-acetyl-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile

4-[(3aS,4R,9bR)-1-acetyl-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile

C22H23N3O2 (361.1790178)


   

4-[(3aR,4R,9bS)-1-acetyl-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile

4-[(3aR,4R,9bS)-1-acetyl-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile

C22H23N3O2 (361.1790178)


   

4-[(3aS,4S,9bR)-1-acetyl-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile

4-[(3aS,4S,9bR)-1-acetyl-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-8-yl]benzonitrile

C22H23N3O2 (361.1790178)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(7Z,9E,11E,14S,16Z,19Z)-13,14-dihydroxydocosa-7,9,11,16,19-pentaenoate

(7Z,9E,11E,14S,16Z,19Z)-13,14-dihydroxydocosa-7,9,11,16,19-pentaenoate

C22H33O4- (361.23787180000005)


   

(7Z,10Z,12E,14S,16Z,19Z)-14,21-dihydroxydocosa-7,10,12,16,19-pentaenoate

(7Z,10Z,12E,14S,16Z,19Z)-14,21-dihydroxydocosa-7,10,12,16,19-pentaenoate

C22H33O4- (361.23787180000005)


   

(7R,8E,10E,12Z,14S,16Z,19Z)-7,14-dihydroxydocosa-8,10,12,16,19-pentaenoate

(7R,8E,10E,12Z,14S,16Z,19Z)-7,14-dihydroxydocosa-8,10,12,16,19-pentaenoate

C22H33O4- (361.23787180000005)


   

7,17-dihydroxy-(8Z,15E,19Z)-docosa-8,10,13,15,19-pentaenoate

7,17-dihydroxy-(8Z,15E,19Z)-docosa-8,10,13,15,19-pentaenoate

C22H33O4- (361.23787180000005)


A docosanoid anion that is the conjugate base of 7,17-dihydroxy-(8Z,15E,19Z)-docosa-8,10,13,15,19-pentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(7Z,10R,11E,13E,15Z,17S,19Z)-10,17-dihydroxydocosa-7,11,13,15,19-pentaenoate

(7Z,10R,11E,13E,15Z,17S,19Z)-10,17-dihydroxydocosa-7,11,13,15,19-pentaenoate

C22H33O4- (361.23787180000005)


   

(7Z,10Z,12E,14E,17S,19Z)-16,17-dihydroxydocosa-7,10,12,14,19-pentaenoate

(7Z,10Z,12E,14E,17S,19Z)-16,17-dihydroxydocosa-7,10,12,14,19-pentaenoate

C22H33O4- (361.23787180000005)


   

(3R,11R)-11-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxydodecanoate

(3R,11R)-11-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxydodecanoate

C18H33O7- (361.22261679999997)


   

(3R)-12-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxydodecanoate

(3R)-12-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxydodecanoate

C18H33O7- (361.22261679999997)


   

(7Z,10Z,12E,14S,16Z,19Z)-14-hydroperoxydocosa-7,10,12,16,19-pentaenoate

(7Z,10Z,12E,14S,16Z,19Z)-14-hydroperoxydocosa-7,10,12,16,19-pentaenoate

C22H33O4- (361.23787180000005)


   

(7Z,10Z,13Z,15E,17S,19Z)-17-hydroperoxydocosa-7,10,13,15,19-pentaenoate

(7Z,10Z,13Z,15E,17S,19Z)-17-hydroperoxydocosa-7,10,13,15,19-pentaenoate

C22H33O4- (361.23787180000005)


   

Butyl N-trifluoroacetyl 1-aminobutylphosphonate

Butyl N-trifluoroacetyl 1-aminobutylphosphonate

C14H27F3NO4P (361.16297080000004)


   

4-(2-Butanoyloxy-3-propanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

4-(2-Butanoyloxy-3-propanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C17H31NO7 (361.21004159999995)


   

4-(3-Acetyloxy-2-pentanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

4-(3-Acetyloxy-2-pentanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C17H31NO7 (361.21004159999995)


   

carbocromen

carbocromen

C20H27NO5 (361.18891320000006)


C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents

   

resolvin T4(1-)

resolvin T4(1-)

C22H33O4 (361.23787180000005)


A docosanoid anion that is the conjugate base of resolvin T4, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

14(S),21-dihydroxy-(7Z,10Z,12E,16Z,19Z)-docosapentaenoate

14(S),21-dihydroxy-(7Z,10Z,12E,16Z,19Z)-docosapentaenoate

C22H33O4 (361.23787180000005)


A docosanoid anion that is the conjugate base of 14(S),21-dihydroxy-(7Z,10Z,12E,16Z,19Z)-docosapentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(7R,14S)-dihydroxy-(8E,10E,12Z,16Z,19Z)-docosapentaenoate

(7R,14S)-dihydroxy-(8E,10E,12Z,16Z,19Z)-docosapentaenoate

C22H33O4 (361.23787180000005)


A docosanoid anion that is the conjugate base of (7R,14S)-dihydroxy-(8E,10E,12Z,16Z,19Z)-docosapentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(10R,17S)-dihydroxy-(7Z,11E,13E,15Z,19Z)-docosapentaenoate

(10R,17S)-dihydroxy-(7Z,11E,13E,15Z,19Z)-docosapentaenoate

C22H33O4 (361.23787180000005)


A docosanoid anion that is the conjugate base of (10R,17S)-dihydroxy-(7Z,11E,13E,15Z,19Z)-docosapentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

16,17(S)-dihydroxy-(7Z,10Z,13E,14E,19Z)-docosapentaenoate

16,17(S)-dihydroxy-(7Z,10Z,13E,14E,19Z)-docosapentaenoate

C22H33O4 (361.23787180000005)


A docosanoid anion that is the conjugate base of 16,17(S)-dihydroxy-(7Z,10Z,13E,14E,19Z)-docosapentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

bhas#20(1-)

bhas#20(1-)

C18H33O7 (361.22261679999997)


Conjugate base of bhas#20

   

(7Z,10Z,12E,14S,16Z,19Z)-14-hydroperoxydocosapentaenoate

(7Z,10Z,12E,14S,16Z,19Z)-14-hydroperoxydocosapentaenoate

C22H33O4 (361.23787180000005)


A (7Z,10Z,12E,16Z,19Z)-14-hydroperoxydocosapentaenoate in which the chiral centre at position 14 has S-configuration.

   

(7Z,10Z,13Z,15E,17S,19Z)-17-hydroperoxydocosapentaenoate

(7Z,10Z,13Z,15E,17S,19Z)-17-hydroperoxydocosapentaenoate

C22H33O4 (361.23787180000005)


A (7Z,10Z,13Z,15E,19Z)-17-hydroperoxydocosapentaenoate in which the chiral centre at position 17 has S-configuration. An intermediate of specialised proresolving mediators.

   

13,14(S)-dihydroxy-(7Z,9E,11E,16Z,19Z)-docosapentaenoate

13,14(S)-dihydroxy-(7Z,9E,11E,16Z,19Z)-docosapentaenoate

C22H33O4 (361.23787180000005)


A docosanoid anion that is the conjugate base of 13,14(S)-dihydroxy-(7Z,9E,11E,16Z,19Z)-docosapentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

bhos#20(1-)

bhos#20(1-)

C18H33O7 (361.22261679999997)


Conjugate base of bhos#20

   

N-Deacetylipecoside aglycone

N-Deacetylipecoside aglycone

C19H23NO6 (361.1525298)


   
   
   
   
   
   
   

H-Ile-Pro-Pro-OH (hydrochloride)

H-Ile-Pro-Pro-OH (hydrochloride)

C16H28ClN3O4 (361.1768238)


H-Ile-Pro-Pro-OH hydrochloride, a milk-derived peptide[1], inhibits angiotensin-converting enzyme (ACE)[1] with an IC50 of 5 μM[2]. Antihypertensive tripeptides[1].

   

SR59230A (hydrochloride)

SR59230A (hydrochloride)

C21H28ClNO2 (361.18084580000004)


SR59230A hydrochloride is a potent, selective, and blood-brain barrier penetrating β3-adrenergic receptor antagonist[1] with IC50s of 40, 408, and 648 nM for β3, β1, and β2 receptors, respectively[2].

   

(13s)-13-[(2r,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,13-dihydroxytridecan-4-one

(13s)-13-[(2r,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,13-dihydroxytridecan-4-one

C18H35NO6 (361.24642500000004)


   

2-hydroxy-9a-methoxy-3,4a,5-trimethyl-4h,5h,6h,7h,8h,8ah,9h-cyclohexa[f]indol-6-yl 2-methylbut-2-enoate

2-hydroxy-9a-methoxy-3,4a,5-trimethyl-4h,5h,6h,7h,8h,8ah,9h-cyclohexa[f]indol-6-yl 2-methylbut-2-enoate

C21H31NO4 (361.22529660000004)


   

(1s,2s,6r,8s,9s,10s)-9,15,16-trimethoxy-3-methyl-7,11-dioxa-3-azapentacyclo[8.8.0.0²,⁶.0⁶,⁸.0¹³,¹⁸]octadeca-13(18),14,16-trien-12-one

(1s,2s,6r,8s,9s,10s)-9,15,16-trimethoxy-3-methyl-7,11-dioxa-3-azapentacyclo[8.8.0.0²,⁶.0⁶,⁸.0¹³,¹⁸]octadeca-13(18),14,16-trien-12-one

C19H23NO6 (361.1525298)


   

6-methoxy-13,16-dimethyl-19-(prop-1-en-2-yl)-15-oxa-4-azapentacyclo[14.3.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰]icosa-2(14),3(11),5(10),6,8,12-hexaene

6-methoxy-13,16-dimethyl-19-(prop-1-en-2-yl)-15-oxa-4-azapentacyclo[14.3.1.0²,¹⁴.0³,¹¹.0⁵,¹⁰]icosa-2(14),3(11),5(10),6,8,12-hexaene

C24H27NO2 (361.2041682)


   

4,5,17-trimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraene-13,16-diol

4,5,17-trimethoxy-11-azatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraene-13,16-diol

C20H27NO5 (361.18891320000006)


   

3-(acetyloxy)-1-[(10z)-8-methyl-2-oxa-6-azatricyclo[5.3.0.0¹,³]deca-6,8-dien-10-ylidene]butan-2-yl 2-methylbutanoate

3-(acetyloxy)-1-[(10z)-8-methyl-2-oxa-6-azatricyclo[5.3.0.0¹,³]deca-6,8-dien-10-ylidene]butan-2-yl 2-methylbutanoate

C20H27NO5 (361.18891320000006)


   

(4as,5r,6s,8ar,9ar)-2-hydroxy-9a-methoxy-3,4a,5-trimethyl-4h,5h,6h,7h,8h,8ah,9h-cyclohexa[f]indol-6-yl (2z)-2-methylbut-2-enoate

(4as,5r,6s,8ar,9ar)-2-hydroxy-9a-methoxy-3,4a,5-trimethyl-4h,5h,6h,7h,8h,8ah,9h-cyclohexa[f]indol-6-yl (2z)-2-methylbut-2-enoate

C21H31NO4 (361.22529660000004)


   

(1s,4s,9s,12s,13s,16r,17r)-17-(hydroxymethyl)-9-methoxy-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5,7-diene-7,17-diol

(1s,4s,9s,12s,13s,16r,17r)-17-(hydroxymethyl)-9-methoxy-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5,7-diene-7,17-diol

C21H31NO4 (361.22529660000004)


   

(1r,4r,5r,13s,14s)-4-hydroxy-5,8-dimethoxy-13-methyl-6-oxa-13-azapentacyclo[8.6.2.1¹,⁵.0⁷,¹⁷.0¹⁴,¹⁸]nonadeca-7(17),8,10(18)-trien-13-ium-13-olate

(1r,4r,5r,13s,14s)-4-hydroxy-5,8-dimethoxy-13-methyl-6-oxa-13-azapentacyclo[8.6.2.1¹,⁵.0⁷,¹⁷.0¹⁴,¹⁸]nonadeca-7(17),8,10(18)-trien-13-ium-13-olate

C20H27NO5 (361.18891320000006)


   

13-[3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,13-dihydroxytridecan-4-one

13-[3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,13-dihydroxytridecan-4-one

C18H35NO6 (361.24642500000004)


   

(1r,2s,3s,5r,7s,10r,11s,13r,14r,17s,18s,19r)-4-ethyl-10-methyl-6-oxa-4-azaheptacyclo[15.2.1.0²,⁷.0²,¹¹.0³,¹³.0⁵,¹⁰.0¹⁴,¹⁹]icosane-13,14,18-triol

(1r,2s,3s,5r,7s,10r,11s,13r,14r,17s,18s,19r)-4-ethyl-10-methyl-6-oxa-4-azaheptacyclo[15.2.1.0²,⁷.0²,¹¹.0³,¹³.0⁵,¹⁰.0¹⁴,¹⁹]icosane-13,14,18-triol

C21H31NO4 (361.22529660000004)


   

(1s,4s,9s,12s,13r,16r,17r)-17-(hydroxymethyl)-9-methoxy-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5,7-diene-7,17-diol

(1s,4s,9s,12s,13r,16r,17r)-17-(hydroxymethyl)-9-methoxy-12-methyl-8-azapentacyclo[14.2.1.0¹,¹³.0⁴,¹².0⁵,⁹]nonadeca-5,7-diene-7,17-diol

C21H31NO4 (361.22529660000004)